$LRCX

Tech Sell-Off: This All-Star Artificial Intelligence Stock Is Down 50% but Up 127,300% Since Its IPO. Here's Why It's a Screaming Buy Heading Into the Midterms.

Lam Research (LRCX) stock is down 50% from its June high but up 127,300% since its 1984 IPO. The semiconductor equipment maker reported record Q3 revenue of $8.22B and EPS of $2.20, beating estimates. Despite strong results, the stock fell due to 'light' guidance of $8.6B revenue and $2.33 EPS for Q4, attributed to supply constraints. Management forecasts industrywide wafer front-end equipment spending to exceed $200B by 2027, with Lam expected to grow faster than the industry.

Original reporting
Published Oct 27, 2026, 10:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 10:36 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Tech Sell-Off: This All-Star Artificial Intelligence Stock Is Down 50% but Up 127,300% Since Its IPO. Here's Why It's a Screaming Buy Heading Into the Midterms. — source image
Decision brief

The 30-second read

$LRCXBearishMed
01

Why it matters

The earnings beat was offset by cautious guidance, leading to a sharp sell‑off; analysts may downgrade the stock.

02

Market read

The report highlights a potential short‑term weakness for AI‑related hardware supply chain stocks.

03

What to watch

Supply‑chain constraints and upcoming NAND demand could support earnings recovery later in 2027.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Lam Research, a leading semiconductor equipment supplier, posted strong Q3 results but issued guidance perceived as light amid AI‑driven demand constraints.

Company-level read

Ticker impact

$LRCXBearishHigh confidence
Context

Lam Research reported Q3 revenue of $8.22B and EPS $2.20, then guided $8.6B revenue and $2.33 EPS, which is viewed as light guidance causing a post‑earnings sell‑off.

Expected impact

likely pressure as investors price in weaker-than‑expected guidance

Evidence & confidence

The guidance is lower than consensus, and the stock already fell 50% from its highs; market reaction suggests continued weakness.

Market effects

May weigh on other semiconductor equipment makers as AI demand expectations are tempered.

US semiconductor sector could see modest pullback in the near term.

Limited to tech‑heavy markets; broader indices likely unaffected.

Counterpoint

Long‑term investors may view the dip as a buying opportunity given Lam's strong market position and growth outlook.

Key entities

  • Lam Research

    Semiconductor equipment manufacturer (NASDAQ:LRCX).

Related articles

$LRCXMed

Lam Research Stock Is 45% Below Its High. How Deep Have Past Drops Gone?

Lam Research (LRCX) shares have fallen 45.1% from their June 30 high, despite reporting record revenue. Historically, the stock has declined more than the S&P 500 during market shocks, with an average drop of 22.8%. The company's operating margin is at a 40-quarter high, and it holds $7.44 billion in cash. Management cited supply chain constraints for a cautious revenue forecast.

$LRCXMed

Lam Research Stocks Gain 4.3% Despite Citi's Target Cut

Lam Research (LRCX) shares rose 4.3% to $239.93 on October 26, despite Citi cutting its price target while maintaining a Buy rating. The company projected December-quarter revenue of $8.6 billion, with a 40.2% adjusted operating margin in September. Investors will watch for earnings growth to meet expectations.

$METAMedAI 8/10

Does enough capital exist to finance everyone’s ambitious AI spending plans?

Meta reported a 26% revenue increase to $64.6B, but negative free cash flow of -$2.1B. The company raised its 2026 capital spending forecast to $135B-$145B and announced new non-voting shares. Executives from Broadcom, BlackRock, and Nvidia expressed concerns about capital scarcity for AI development. AI-linked stocks like Nvidia, CoreWeave, and Lam Research fell, while broader market indices showed mixed performance. Treasury yields also declined.

$AAPLMed

5 big analyst AI moves: ’Uniquely catalyst-rich’ months ahead for SpaceX

Loop Capital downgraded Apple to Hold, cutting its price target to $330 and lowering iPhone revenue forecasts. JPMorgan upgraded Intel to Neutral, citing balanced risk-reward. Citi initiated a positive Catalyst Watch on SpaceX, highlighting upcoming catalysts. Mizuho reiterated Outperform on Lam Research, recommending buying on pullback. Yardeni Research noted an AI bubble but said it's not yet close to bursting.

$LRCXHighAI 8/10

The Pareto Investor (@paretoinvestor)

Lam Research reported record revenue of $8.22B, beating estimates, but its CFO cited supply chain constraints for lower-than-expected guidance. Shares fell 11%, and other chip-related stocks like Nvidia, Qualcomm, Marvell, Intel, Applied Materials, and ASML also declined. The downturn reflects broader chip sector volatility and supply chain concerns.

$LRCXMed

Lam Says U.S. Export Rules Limit China Revenue as Share Rebounds to 35%

Lam Research reported that U.S. export rules have reduced its China revenue, which accounted for 35% of its $8.27 billion in sales for the quarter ended Sept. 27. This is up from 26% in June but down from 43% in the same period last year. The company warned that the impact of these rules could increase, affecting its future revenue. Lam projected revenue of $8.6 billion for the next quarter.